Helping kids hear the future
Fennec Pharmaceuticals is a biotechnology company dedicated to improving the lives of children with cancer who experience hearing loss as a result of chemotherapy.
Latest News
- FENNEC PHARMACEUTICALS REPORTS FULL YEAR AND FOURTH QUARTER 2023 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
- FENNEC PHARMACEUTICALS TO REPORT FULL YEAR AND FOURTH QUARTER 2023 FINANCIAL RESULTS ON MARCH 21, 2024
- FENNEC PHARMACEUTICALS AND NORGINE ENTER INTO EXCLUSIVE LICENSING AGREEMENT TO COMMERCIALIZE PEDMARQSI IN EUROPE, AUSTRALIA, AND NEW ZEALAND
- FENNEC PHARMACEUTICALS REPORTS PRELIMINARY UNAUDITED NET REVENUE FOR FOURTH QUARTER AND FULL-YEAR 2023 RESULTS
- FENNEC PHARMACEUTICALS ANNOUNCES SECOND CLOSING OF $20 MILLION INVESTMENT FROM PETRICHOR